AHK-Cu: The Hair Copper Peptide With One Lab Study
AHK-Cu is a copper tripeptide marketed for hair growth. Its evidence is one 2007 lab study on human follicles. Mechanism, doses people use, and risks.
Peptide Therapy
Limited EvidenceCopper-binding tripeptide used in topical skincare; injectable use has no human trial evidence. Evidence, safety and regulatory status.
AHK-Cu is a copper tripeptide marketed for hair growth. Its evidence is one 2007 lab study on human follicles. Mechanism, doses people use, and risks.
GLOW is a vendor blend, usually GHK-Cu 50 mg, BPC-157 10 mg and TB-500 10 mg. What each part does, the untested combination, quality data and protocols.
KLOW is a vendor blend of GHK-Cu 50 mg, BPC-157, TB-500 and KPV 10 mg each. Components, the missing combination data, lab-test results and protocols.
Dr. Douwes reviews the evidence for peptide-based hair loss therapy — GHK-Cu, TB-500, KGF, and PTD-DBM — with dosing, mechanisms, and realistic expectations.
Learn how to combine therapeutic peptides like BPC-157, TB-500, and GHK-Cu, with dosing protocols, the clinical evidence, and the safety questions.
Dr. med. univ. Julian Douwes ranks the most effective peptides for tissue repair, wound healing, and recovery — with dosing context and evidence grades for each.
A physician's evidence-based guide to peptide therapy for women — covering hormonal interactions, key peptides, dosing considerations, and who is a suitable candidate.
GHK-Cu copper peptide for skin anti-aging. Collagen synthesis, wrinkle reduction evidence, topical vs injectable protocols, and retinol comparison.
Complete GHK-Cu dosing guide. Topical concentrations, subcutaneous injection protocols, microneedling delivery, and combination strategies.
GHK-Cu copper peptide review. Gene expression modulation, wound healing, skin rejuvenation, and anti-aging research assessed by Dr. med. univ. Julian Douwes.